Internal Medicine, Hematology & Oncology · Kansas City, MO
NPI
1093747677
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
8
Medicare group memberships
Hospitals
5
Hospital affiliations
2316 E Meyer Blvd, 1 East
Kansas City, MO, 64132
Phone (816) 974-5050
Groups this clinician bills Medicare through
Medicare paid, 2024
$309K
4,864 services
Medicare patients, 2024
1,281
Average age 74
Drug cost, 2024
$10.5M
6,497 prescriptions
Company payments, 2025
$7,051
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jaswinder Singh was code 99214 (office e&m - established), 1,697 times for 852 patients. In total Jaswinder Singh billed 4,864 services in 30 codes, and Medicare paid $309K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,697 | 852 | $68.66 | $117K |
| 99232 Hospital E&M - Subsequent | Facility | 467 | 144 | $59.41 | $28K |
| 99233 Hospital E&M - Subsequent | Facility | 434 | 169 | $88.32 | $38K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 272 | 40 | $141.48 | $38K |
| 99213 Office E&M - Established | Facility | 218 | 202 | $44.83 | $9,772 |
| 99223 Hospital E&M - Initial | Facility | 139 | 121 | $126.98 | $18K |
| 99215 Office E&M - Established | Facility | 100 | 76 | $108.21 | $11K |
| 99214 Office E&M - Established | Office | 82 | 55 | $82.12 | $6,734 |
| 96402 Chemotherapy Administration | Office | 80 | 39 | $24.45 | $1,956 |
| 99204 Office E&M - New | Facility | 71 | 71 | $96.16 | $6,827 |
| 99203 Office E&M - New | Facility | 48 | 48 | $47.95 | $2,301 |
| 99204 Office E&M - New | Office | 45 | 45 | $118.56 | $5,335 |
| 99231 Hospital E&M - Subsequent | Facility | 19 | 16 | $37.80 | $718 |
| 85025 Blood Count | Office | 16 | 15 | $7.61 | $122 |
| 84153 Clinical Chemistry | Office | 16 | 15 | $18.02 | $288 |
By year: 2022 $276K for 3,866 services; 2023 $243K for 3,597 services; 2024 $309K for 4,864 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84153 Clinical Chemistry | 16 | 15 | $18.02 | $288 |
| 85025 Blood Count | 16 | 15 | $7.61 | $122 |
| 80053 Clinical Chemistry | 15 | 14 | $10.35 | $155 |
Medicare prescription drug claims, 2024
In 2024, the drug Jaswinder Singh prescribed most often to Medicare patients was Prednisone, with 696 prescriptions and refills. In total Jaswinder Singh wrote 6,497 Medicare prescriptions that cost $10.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 696 | 868 | 194 | $3,703 |
| Anastrozole Generic | 435 | 983 | 107 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 399 | 399 | 133 | $10K |
| Abiraterone Acetate Generic | 330 | 355 | 57 | $542K |
| Gabapentin Generic | 249 | 304 | 73 | $3,642 |
| Potassium Chloride Generic | 191 | 265 | 75 | $3,849 |
| Eliquis Apixaban | 177 | 204 | 41 | $119K |
| Oxycodone Hcl Generic | 155 | 156 | 41 | $3,505 |
| Tamoxifen Citrate Generic | 149 | 339 | 41 | $2,909 |
| Alprazolam Generic | 126 | 126 | 35 | $630 |
| Bicalutamide Generic | 103 | 191 | 38 | $3,095 |
| Xarelto Rivaroxaban | 88 | 136 | 20 | $73K |
| Levothyroxine Sodium Generic | 87 | 159 | 33 | $627 |
| Methylprednisolone Generic | 87 | 87 | 74 | $577 |
| Hydroxyurea Generic | 85 | 153 | 24 | $2,067 |
Brand drugs: - claims; generic drugs: 5,466 claims; opioid claims: 900.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jaswinder Singh $7,051 ($7,051 in general payments such as food, travel and fees) from 50 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $2,333.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 24 | $2,333 |
| Abbvie Inc. ABBV | 33 | $698 |
| Pfizer Inc. PFE | 32 | $482 |
| GlaxoSmithKline, LLC. GSK | 18 | $367 |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $355 |
| Merck Sharp & Dohme LLC MRK | 15 | $316 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $282 |
| TerSera Therapeutics LLC | 8 | $195 |
| Eisai Inc. 4523.T | 12 | $187 |
| Caris MPI, Inc. | 1 | $161 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.